Livogiva Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

livogiva

theramex ireland limited - teriparatíð - beinþynning - kalsíumsterastasis - livogiva is indicated in adults. meðferð við beinþynningu hjá konum eftir tíðahvörf og karlar við aukna hættu á beinbrotum. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. meðferð beinbrot tengslum við viðvarandi almenn sykurstera meðferð í konur og menn á jókst hættan fyrir beinbrot.

Vaxneuvance Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - sýkingar af völdum pneumókokka - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. sjá kafla 4. 4 og 5. 1 til að fá upplýsingar um vernd gegn tilteknum sermigerðum pneumokokkum. the use of vaxneuvance should be in accordance with official recommendations.

Arzotilol (Dorzolamid + Timolol Actavis) Augndropar, lausn 20 mg/ml +5 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

arzotilol (dorzolamid + timolol actavis) augndropar, lausn 20 mg/ml +5 mg/ml

teva b.v.* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml +5 mg/ml

Bactroban Smyrsli 20 mg/g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban smyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum inn - smyrsli - 20 mg/g

Bactroban Nasal Nefsmyrsli 20 mg/g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban nasal nefsmyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum kalsíum - nefsmyrsli - 20 mg/g

Cosopt sine Augndropar, lausn 20 mg/ml+5 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml

santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml

Dorzolamide/Timolol Alvogen Augndropar, lausn 20mg/ml+5 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml

alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml

Enrylaze Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

enrylaze

jazz pharmaceuticals ireland limited - crisantaspase - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.